These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Some behavioral effects of delta9 -tetrahydrocannabinol in rats. Pradhan SN; Bailey PT; Ghosh B Res Commun Chem Pathol Pharmacol; 1972 Mar; 3(2):197-204. PubMed ID: 4610672 [No Abstract] [Full Text] [Related]
6. Lack of cross-tolerance in rats among (-)delta9-trans-tetrahydrocannabinol(delta9-THC), cannabis extract, mescaline and lysergic acid diethylamide (LSD-25). Teresa M; Silva A; Carlini EA; Claussen U; Korte F Psychopharmacologia; 1968; 13(4):332-40. PubMed ID: 5722169 [No Abstract] [Full Text] [Related]
7. Effects of cannabidiol and delta-9-tetrahydrocannabinol on operant behavior. Davis WM; Borgen LA Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):453-62. PubMed ID: 4445565 [No Abstract] [Full Text] [Related]
8. Delta9-tetrahydrocannabinol and some CNS depressants: evidence for cross-tolerance in the rat. Newman LM; Lutz MP; Domino EF Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):254-9. PubMed ID: 4827412 [No Abstract] [Full Text] [Related]
9. Effects of delta9-tetrahydrocannabinol and cannabinol on operant performance in rats. Karniol IG; Takahashi RN; Musty RE Arch Int Pharmacodyn Ther; 1974 Dec; 212(2):230-7. PubMed ID: 4447406 [No Abstract] [Full Text] [Related]
10. Development of tolerance in pigeons to behavioral effects of a new benzopyran derivative. Campo RA J Pharmacol Exp Ther; 1973 Mar; 184(3):521-7. PubMed ID: 4687218 [No Abstract] [Full Text] [Related]
11. General and behavioral pharmacology. Harris LS Pharmacol Rev; 1971 Dec; 23(4):285-94. PubMed ID: 4943947 [No Abstract] [Full Text] [Related]
12. Tolerance to active constituents of marihuana. McMillan DE; Ford RD; Frankenheim JM; Harris RA; Harris LS Arch Int Pharmacodyn Ther; 1972; 198(1):132-44. PubMed ID: 5053235 [No Abstract] [Full Text] [Related]
13. Effects of drugs on behavior in pigeons tolerant to delta 9-tetrahydrocannabinol. McMillan DE; Leander JD; Dudley KH J Pharmacol Exp Ther; 1980 Jan; 212(1):85-90. PubMed ID: 7351628 [TBL] [Abstract][Full Text] [Related]
14. Acquisition and extinction of variable interval schedule behavior by rats under delta9-tetrahydrocannabinol. Ferraro DP; Gluck JP; Herndon GB Pharmacol Biochem Behav; 1974; 2(4):487-91. PubMed ID: 4421520 [No Abstract] [Full Text] [Related]
15. Blood levels of 3 H- 9 -tetrahydrocannabinol and its metabolites in tolerant and nontolerant pigeons. McMillan DE; Dewey WL; Turk RF; Harris LS; McNeil JH Biochem Pharmacol; 1973 Feb; 22(3):383-97. PubMed ID: 4687134 [No Abstract] [Full Text] [Related]
16. Effects of acute and chronic administration of cannabis sativa and (-) delta9-trans-tetrahydrocannabinol on the behavior of rats in an open-field arena. Masur J; Märtz RM; Carlini EA Psychopharmacologia; 1971; 19(4):388-97. PubMed ID: 5565250 [No Abstract] [Full Text] [Related]
17. Acute tolerance to the effects of delta-9-tetrahydrocannabinol on spaced responding by monkeys. Manning FJ Pharmacol Biochem Behav; 1973; 1(6):665-71. PubMed ID: 4206609 [No Abstract] [Full Text] [Related]
18. Tolerance to the reinforcing effects of morphine in delta9-tetrahydrocannabinol treated mice. Jardinaud F; Roques BP; Noble F Behav Brain Res; 2006 Oct; 173(2):255-61. PubMed ID: 16884789 [TBL] [Abstract][Full Text] [Related]
19. Marihuana on locomotor activity: biphasic effect and tolerance development. Davis WM; Moreton JE; King WT; Pace HB Res Commun Chem Pathol Pharmacol; 1972 Jan; 3(1):29-35. PubMed ID: 5030706 [No Abstract] [Full Text] [Related]
20. Distribution of radioactivity in brain of tolerant and nontolerant pigeons treated with 3 H- 9 -tetrahydrocannabinol. Dewey WL; McMillan DE; Harris LS; Turk RF Biochem Pharmacol; 1973 Feb; 22(3):399-405. PubMed ID: 4687135 [No Abstract] [Full Text] [Related] [Next] [New Search]